Aseptic meningitis and intravenous immunoglobulin therapy.

Abstract

Letters15 February 1995Aseptic Meningitis and Intravenous Immunoglobulin TherapyYadollah Harati and Aziz Taher ShaibaniYadollah HaratiSearch for more papers by this author and Aziz Taher ShaibaniSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-122-4-199502150-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Sekul and colleagues [1] described the association between aseptic meningitis and high-dose intravenous immunoglobulin and reported that 11% (6 of 54) of their patients developed aseptic meningitis after receiving intravenous immunoglobulin. However, they did not mention the specific immunoglobulin product or products they used, although they asserted that a change in the “commercial lot or product, for unknown reasons, was effective in preventing the recurrence of aseptic meningitis”.Considering the high incidence of aseptic meningitis reported by these authors and the fact that different intravenous immunoglobulin products vary in the type and amount of the vehicle and ...REFERENCE1. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994; 121:259-62. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAcute Aseptic Meningitis Associated with Administration of Immunoglobulin in Children: A Case Report and Review of the Literature 15 February 1995Volume 122, Issue 4Page: 316-317KeywordsIntravenous immunoglobulinMeningitis ePublished: 15 August 2000 Issue Published: 15 February 1995 Copyright & PermissionsCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...